Eiger BioPharmaceuticals
A biopharmaceutical company developing drugs for the treatment of rare diseases
7
Funding Rounds
$74.8m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Ap***** | - | - | - |
| Am** K. Sa***** | - | - | |
| Da*** Co** | - | - | |
| Ch******* Mu**** | - | - | - |
Funding series
Funding Series Analysis
The company Eiger BioPharmaceuticals has raised a total of $7.1m in funding over 7 rounds.
Key Insights:
- Eiger BioPharmaceuticals Series A round: $7.1m
- Celladon Corp funding round, October 2011: $200k
- Celladon Corp funding round, December 2011: $500k
- Celladon Corp funding round, February 2012: $61.35m
- Celladon Corp funding round, October 2013: $2.4m
- Eiger BioPharmaceuticals, Inc. funding round, April 2016: $3m
- Celladon Corp funding round, August 2011: $250k
Eiger BioPharmaceuticals Series A round
$7.1m
Celladon Corp funding round, October 2011
$200k
Celladon Corp funding round, December 2011
$500k
Celladon Corp funding round, February 2012
$61.35m
Celladon Corp funding round, October 2013
$2.4m
Eiger BioPharmaceuticals, Inc. funding round, April 2016
$3m
Celladon Corp funding round, August 2011
$250k
Industries
Eiger BioPharmaceuticals is active in the following industries:
- Technology
- Biomedical engineering
- Biology
- Biotechnology
- Engineering
- Synthetic chemistry